Edition:
United Kingdom

Exact Sciences Corp (EXAS.OQ)

EXAS.OQ on NASDAQ Stock Exchange Capital Market

67.62USD
20 Jul 2018
Change (% chg)

$0.01 (+0.01%)
Prev Close
$67.61
Open
$67.86
Day's High
$69.20
Day's Low
$67.57
Volume
345,970
Avg. Vol
709,113
52-wk High
$71.55
52-wk Low
$36.13

Chart for

About

Exact Sciences Corporation is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA)... (more)

Overall

Beta: 0.64
Market Cap(Mil.): $5,791.66
Shares Outstanding(Mil.): 119.10
Dividend: --
Yield (%): --

Financials

  EXAS.OQ Industry Sector
P/E (TTM): -- 85.33 32.76
EPS (TTM): -1.29 -- --
ROI: -34.68 2.22 14.61
ROE: -35.62 3.86 16.34

UPDATE 1-American Cancer Society recommends earlier colorectal cancer screening

May 30 The American Cancer Society on Wednesday recommended that people at average risk of colorectal cancer start regular screening at the age of 45 rather than at 50, at a time when studies show a rise in cases of the disease among younger individuals.

30 May 2018

BRIEF-Exact Sciences Says CEO Kevin T. Conroy's 2017 Total Compensation Was $13.3 Million

* EXACT SCIENCES CORP SAYS CEO KEVIN T. CONROY'S 2017 TOTAL COMPENSATION WAS $13.3 MILLION – SEC FILING Source : https://bit.ly/2w2gEbC Further company coverage: (Reuters.Briefs@thomsonreuters.com)

30 Apr 2018

BRIEF-Exact Sciences reports Q1 Loss Per Share of $0.33

* Q1 EARNINGS PER SHARE VIEW $-0.37 -- THOMSON REUTERS I/B/E/S

26 Apr 2018

BRIEF-Mark Stenhouse To Join Exact Sciences As President, Cologuard

* MARK STENHOUSE TO JOIN EXACT SCIENCES AS PRESIDENT, COLOGUARD

20 Mar 2018

BRIEF-Exact Sciences Q4 Loss Per Share $0.18

* ANTICIPATES COMPLETED COLOGUARD TEST VOLUME OF 900,000-920,000 TESTS DURING 2018.

22 Feb 2018

Competitors

  Price Chg
Quest Diagnostics Inc (DGX.N) $114.46 -0.53
Epigenomics AG (ECXn.F) €2.44 +0.04
GeneNews Ltd (GEN.TO) $0.08 +0.01

Earnings vs. Estimates